Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease. uri icon

Overview

publication date

  • December 1, 2015

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Crohn Disease
  • Gastrointestinal Agents
  • Infliximab

Identity

Scopus Document Identifier

  • 84951001359

Digital Object Identifier (DOI)

  • 10.1038/ajg.2015.355

PubMed ID

  • 26673509

Additional Document Info

volume

  • 110

issue

  • 12